Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biological standardization of allergenic extracts of Dermatophagoides farinae and Lolium perenne
2013-003270-28Phase 2Completed
- Sponsor
- Inmunal
- Start
- Oct 2013
- Modality
- Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of dermatophagoides farinae and Lolium perenne extract in allergic rhinitis (AR), allergic asthma, house dust mite allergy and 1 more (2 arms), sponsored by Inmunal. Primary endpoint: Cutaneous reaction to the extract. Started Oct 2013; status: completed.
02
Drugs
dermatophagoides farinaeLolium perenne extract
03
Conditions
allergic rhinitis (AR)allergic asthmahouse dust mite allergygrass pollen allergy
Beyond the preview
Go deeper on 2013-003270-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003270-28.